S&S Healthcare Holding Ltd. (TPEX:4198)
46.30
-1.00 (-2.11%)
Nov 20, 2026, 1:22 PM CST
S&S Healthcare Holding Revenue
S&S Healthcare Holding had revenue of 56.94M TWD in the quarter ending September 30, 2026, with 29.81% growth. This brings the company's total for the last twelve months to 185.52M, down -9.78% year-over-year. In the year 2025, S&S Healthcare Holding had annual revenue of 204.21M, down -15.00%. That makes S&S Healthcare Holding the 39,622nd largest company in the world by revenue and 2,045th in Taiwan.
Revenue (ttm)
185.52M
Revenue Growth
-9.78%
P/S Ratio
6.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.12B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full S&S Healthcare Holding breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 204.21M | -36.04M | -15.00% |
| Dec 31, 2024 | 240.25M | -14.28M | -5.61% |
| Dec 31, 2023 | 254.52M | 86.00K | 0.03% |
| Dec 31, 2022 | 254.44M | 132.08M | 107.95% |
| Dec 31, 2021 | 122.35M | 20.99M | 20.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| OK Biotech | 1.72B |
| AViTA | 1.05B |
| Bioptik Technology Incorporation | 891.73M |
| Medimaging Integrated Solution | 744.42M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |
| Taiwan Biomaterial | 153.37M |